
Robert Andtbacka
@robertandtbacka
ID: 3140586732
05-04-2015 18:36:24
13 Tweet
102 Followers
111 Following



Just released New Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST ascopubs.org/doi/full/10.12…. Greg Goldmacher Anuradha Khilnani, MD 🇺🇸❤️ Jason Luke, MD, FACP David C. Madoff, MD #itRECIST #oncology #intratumoral #Immunotherapy ascopubs.org/doi/full/10.12…


7and8biopharma reaches a new clinical development milestone for BDB001 monotherapy: First Patient Treated in a Phase 2 Clinical Trial in anti-PD-1 / anti-PD-L1 Refractory Solid Tumors. Full Release: 7and8biopharma.com/seven-and-eigh… #immunotherapy #cancer #oncology #TLR78 #BDB001




FDA Panels Support Approval of T-VEC in Melanoma $amgn shar.es/1pxi5L via OncLive.com | this is great news for IT immunotherapy! $oncs


Thanks presenters Robert Andtbacka, Carvajal Herbert Irving Comprehensive Cancer Center, Hoffner,Postow MSK Oncology Updates , Faries @JohnWayneCI


